Dr. Bhaskar Gurram, M.D

NPI: 1528244597
Total Payments
$7,415
2024 Payments
$614.78
Companies
19
Transactions
169

Payment Breakdown by Category

Food & Beverage$3,254 (43.9%)
Research$2,800 (37.8%)
Travel$745.01 (10.0%)
Education$616.30 (8.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,254 143 43.9%
Unspecified $2,800 4 37.8%
Travel and Lodging $745.01 4 10.0%
Education $616.30 18 8.3%

Payments by Type

General
$4,615
165 transactions
Research
$2,800
3 transactions
Ownership
$0
1 transactions

Top Paying Companies

Company Total Records Latest Year
Janssen Research & Development, LLC $3,780 14 $0 (2022)
Janssen Biotech, Inc. $891.87 32 $0 (2024)
ABBVIE INC. $820.97 46 $0 (2022)
Janssen Scientific Affairs, LLC $391.47 5 $0 (2024)
QOL Medical, LLC $373.08 15 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $345.63 18 $0 (2024)
Mirum Pharmaceuticals, Inc. $172.09 9 $0 (2024)
GENZYME CORPORATION $127.45 4 $0 (2024)
Regeneron Healthcare Solutions, Inc. $98.92 5 $0 (2024)
Alcresta Therapeutics, Inc. $95.92 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $614.78 28 Mirum Pharmaceuticals, Inc. ($172.09)
2023 $439.98 21 Takeda Pharmaceuticals U.S.A., Inc. ($87.97)
2022 $3,105 15 Janssen Research & Development, LLC ($2,800)
2021 $428.43 20 AbbVie Inc. ($273.55)
2020 $515.13 27 AbbVie Inc. ($278.54)
2019 $1,233 20 Janssen Research & Development, LLC ($979.70)
2018 $469.47 18 Janssen Biotech, Inc. ($233.19)
2017 $609.69 20 Janssen Biotech, Inc. ($310.24)

All Payment Transactions

169 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/19/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $20.07 General
Category: Alagille syndrome
12/05/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $13.99 General
Category: INTERNAL MEDICINE
12/03/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Food and Beverage In-kind items and services $13.86 General
Category: Gastroenterology
11/20/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $20.11 General
Category: Alagille syndrome
11/14/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $13.86 General
Category: INTERNAL MEDICINE
11/07/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $34.60 General
Category: Immunology
10/24/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $21.24 General
Category: Alagille syndrome
10/17/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $30.79 General
Category: Immunology
09/26/2024 Mirum Pharmaceuticals, Inc. Cholbam (Drug) Food and Beverage In-kind items and services $18.21 General
Category: Hepatology
09/12/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $19.56 General
Category: INTERNAL MEDICINE
08/22/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $32.49 General
Category: Immunology
08/08/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $18.56 General
Category: Alagille syndrome
07/23/2024 Alcresta Therapeutics, Inc. RELIZORB (Device) Food and Beverage In-kind items and services $21.14 General
Category: GASTROENTEROLOGY
07/18/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $16.63 General
Category: INTERNAL MEDICINE
07/12/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $14.03 General
Category: Alagille syndrome
07/09/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $19.24 General
Category: Alagille syndrome
06/04/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $16.55 General
Category: Immunology
05/21/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $20.67 General
Category: Alagille syndrome
05/09/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $21.61 General
Category: INTERNAL MEDICINE
04/18/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $19.96 General
Category: Alagille syndrome
04/11/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $22.71 General
Category: INTERNAL MEDICINE
03/08/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $21.53 General
Category: INFLAMMATION AND IMMUNOLOGY
03/04/2024 Janssen Scientific Affairs, LLC STELARA (Biological), TREMFYA, REMICADE Food and Beverage In-kind items and services $77.23 General
Category: Immunology
02/29/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $29.57 General
Category: Immunology
02/16/2024 Pharming Healthcare, Inc. RUCONEST (Biological) Food and Beverage In-kind items and services $15.86 General
Category: BIOLOGIC

Research Studies & Clinical Trials

Study Name Company Amount Records
CNTO1275CRD3012 Janssen Research & Development, LLC $1,800 1
CNTO1275CRD3010 Janssen Research & Development, LLC $500.00 1
CNTO1275CRD3011 Janssen Research & Development, LLC $500.00 1

About Dr. Bhaskar Gurram, M.D

Dr. Bhaskar Gurram, M.D is a Pediatrics healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1528244597.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bhaskar Gurram, M.D has received a total of $7,415 in payments from pharmaceutical and medical device companies, with $614.78 received in 2024. These payments were reported across 169 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,254).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatrics, Pediatric Gastroenterology
  • Location Dallas, TX
  • Active Since 01/21/2008
  • Last Updated 08/17/2015
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1528244597

Products in Payments

  • STELARA (Biological) $3,170
  • REMICADE (Biological) $801.27
  • HUMIRA (Biological) $516.28
  • Sucraid (Drug) $319.41
  • GATTEX (Drug) $237.27
  • Humira (Biological) $234.95
  • DUPIXENT (Biological) $226.37
  • Livmarli (Drug) $153.88
  • EOHILIA (Drug) $108.36
  • RELIZORB (Device) $95.92
  • Kanuma (Drug) $63.18
  • SUCRAID (Drug) $53.67
  • Kristalose 10gm (Drug) $41.32
  • CREON (Drug) $38.42
  • RUCONEST (Biological) $33.40
  • Bylvay (Drug) $32.11
  • GED-0301 (Drug) $28.25
  • AMJEVITA (Biological) $24.84
  • AVSOLA (Biological) $22.00
  • Cholbam (Drug) $18.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Dallas